Banco Santander-Chile Announces Third Quarter 2025 Earnings GlobeNewswire October 30, 2025 SANTIAGO, Chile, Oct. 30, 2025 (GLOBE NEWSWIRE) — Banco Santander Chile (NYSE: BSAC; SSE: Bsantander) announced today its results1 for the nine-month period ended September 30, 2025, and third quarter 2025 (3Q25). Solid financial performance with a ROAE2 of 24.0% in 9M253 As of […]
OTC Markets Group Welcomes Lynas Rare Earths Limited to OTCQX GlobeNewswire October 30, 2025 NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Lynas Rare Earths Limited (ASX: LYC; OTCQX: LYSDY, LYSCF), the only commercial producer of
Alta Equipment Group Announces Date of Third Quarter 2025 Financial Results Release, Conference Call and Webcast GlobeNewswire October 30, 2025 LIVONIA, Mich. , Oct. 30, 2025 (GLOBE NEWSWIRE) — Alta Equipment Group Inc. (NYSE: ALTG) (“Alta” or “the Company”), a leading provider of premium material handling, construction and environmental processing equipment and related services, today
Allegro MicroSystems Reports Second Quarter 2026 Results Sales Increased 14% Year-Over-Year to $214 Million GlobeNewswire October 30, 2025 MANCHESTER, N.H., Oct. 30, 2025 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (“Allegro” or the “Company”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced financial results
Axi Attends iFX Expo Asia 2025, Showcases its Products and Services GlobeNewswire October 30, 2025 SYDNEY, Oct. 30, 2025 (GLOBE NEWSWIRE) — Axi, a financial leader in online CFD and FX trading, participated in iFX Expo Asia 2025, held from October 26 to 28, in Asia. The event brought together leading fintech, trading, and financial
Phathom Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update GlobeNewswire October 30, 2025 Over 790,000 total VOQUEZNA(R) prescriptions filled to date Filled VOQUEZNA prescriptions increased 28% from Q2 2025 Net revenues of $49.5 million, up 25% quarter over quarter, and cash operating expenses down 43% quarter over quarter Full-year 2025 revenue guidance
Seres Therapeutics to Announce Third Quarter 2025 Financial Results and Business Updates on November 5, 2025 GlobeNewswire October 30, 2025 CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) — Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will host a conference call and live audio webcast on November 5, 2025 at
Peabody (NYSE: BTU) announced today that its Board of Directors has declared a quarterly dividend on its common stock of $0.075 per share, payable on December 3, 2025 to stockholders of record on November 13, 2025. Peabody is a leading coal producer, providing essential products for the production of affordable, reliable energy and steel. Our
Rebellion Energy Solutions' Heartland 3 Methane Abatement and Land Restoration Project [ACR1023] has received a Carbon Project Rating of AA from MSCI, placing it in the top 10 percent of all carbon projects MSCI has rated. https://mma.prnewswire.com/media/2085862/Rebellion_Energy_Solutions_Logo.jpg The AA-level MSCI Carbon Project Rating, which evaluates the environmental integrity of carbon projects, indicates a “high likelihood”
CAMBRIDGE, United Kingdom, Oct. 30, 2025 (GLOBE NEWSWIRE) — Alistair will lead on the growth and capital strategy for Cambridge Atomworks. Alistair has a passion for investing in companies that have a strong focus in sustainability following an instrumental role building out the EU Emissions Trading Desk for ICAP some 20 years ago. He has